ReviewCells2020
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy.
Ufuk Degirmenci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
304 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewCells2020
Ufuk Degirmenci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.